Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis
- PMID: 29149929
- PMCID: PMC5726432
- DOI: 10.1016/j.rdc.2017.09.005
Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis
Abstract
Gastrointestinal (GI) manifestations of rheumatoid arthritis (RA) are rare, but can be impactful for patients. Some GI processes are directly related to RA, whereas others may be sequelae of treatment or caused by concomitant autoimmune diseases. This article discusses the role of the GI tract in RA pathogenesis; the presentation, epidemiology, and diagnosis of RA-related GI manifestations; concomitant GI autoimmune diseases that may affect those with RA; and GI side effects of RA treatment. The importance of appropriately considering conditions unrelated to RA in the differential diagnosis when evaluating new GI symptoms in patients with RA is noted.
Keywords: Antirheumatic medications (DMARDs); Gastrointestinal disease; Hepatic disease; Rheumatoid arthritis.
Copyright © 2017 Elsevier Inc. All rights reserved.
Figures
References
-
- Ciccia F, Ferrante A, Guggino G, Triolo G. The role of the gastrointestinal tract in the pathogenesis of rheumatic diseases. Best Pract Res Clin Rheumatol. 2016;30(5):889–900. - PubMed
-
- Chen K, Liu J, Cao X. Regulation of type I interferon signaling in immunity and inflammation: a comprehensive review. J Autoimmun. 2017 In press. - PubMed
-
- Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the Prevalence of Arthritis and Other Rheumatic Conditions in the United States Part I. Arthritis Rheumatol. 2008;58(1):15–25. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical